created by IMK

Programm
Freitag 09.11.2012

   Gemeinsam                                  SGVN
SNG Industriesymposium                            
SGBP Pausen

 






08:30-10:00  
Montreal

  Language disfunction in neurology and psychiatry
Chair: Jean-Marie Annoni, Genève; Werner Konrad Strik, Bern

08:30-08:50



  Auditory hallucinations, formal thought disorders and
the language system
Thomas Dierks, Bern

08:50-09:10


    Language functions in schizophrenia
Tilo Kircher, Marburg; Deutschland

09:10-09:30


  Non-verbal and verbal communication in aphasia
Georg Goldenberg, München, Deutschland

09:30-09:50



  Language structure and its dysfunction in primary
progressive aphasias
Marc Teichmann, Paris; France

09:50-10:00

  Discussion

10:00-10:30

  Kaffeepause in der Industrieausstellung

10:30-11:30
Montreal

  Multiple sclerosis
Chair: Michael Linnebank, Zürich; Renaud Du Pasquier, Lausanne

10:30-10:50


  Autoimmune pathogenesis of multiple sclerosis
Roland Martin, Zürich

10:50-11:10


  Differential diagnostics of myelitis: 6 cases and 6 diagnoses
Thomas Berger, Innsbruck; Österreich

11:10-11:30


  MS genetics-What remains to be discovered?
Jan Hillert, Stockholm; Sweden

10:30-11:30
Singapore

  Early recognition and treatment of brain disorders
Chair: Jean Michel Aubry, Genève; Kim Do Cuénod, Genève

10:30-11:00


  Early-life stress programming of mood disorders
Alexandre Dayer, Genève

11:00-11:30


  Towards a staging model in psychotic disorders: the potential benefits of biomarkers in early psychosis
Philippe Conus, Lausanne

11:30-13:30

  Lunch in der Industrieausstellung

12:00-13:00
Montreal



12:00-12:13


12:13-12:33


12:33-12:53


12:53-13:00

  Industriesymposium organisiert durch UCB Pharma AG

Emergencies in Epilepsy – Time is Brain
Chair: Margitta Seeck, Genève

Introduction - When Seizures Require Rapid Action
Margitta Seeck, Genève

Prehospital and Early Stage Approch to Acute Seizures and Status Epilepticus
Eugen Trinka, Salzburg

ICU Management of Epilepsy
Stephan Rüegg, Basel

Discussion

12:00-13:00
Sydney



12:00-12:30


12:30-13:00


  Industriesymposium organisiert durch Vifor Pharma AG

Iron and restless legs syndrome: pathophysiological and clinical aspects
Chair: Claudio Bassetti, Bern

Role of iron in the pathophysiology of restless legs syndrome
Mauro Manconi, Lugano

Intravenous iron in the treatment of Restless Legs Syndrome during pregnancy
Claudio Bassetti, Lugano

13:30-14:30
Montreal











  Annemarie Opprecht - Foundation, Parkinson Award
Matthias Sturzenegger, Bern


Grussbotschaft durch Regierungsrat Dr. Carlo Conti, Vorsteher
des Gesundheitsdepartements Basel-Stadt und Präsident der
Schweizerischen Konferenz der kantonalen Gesundheitsdirektorinnen
und -direktoren

Laudatio [durch M. Sturzenegger]

Hauptreferat des Preisträgers

13:30-14:30
Singapore

  Emotional brain
Chair: Erich Seifritz, Zürich; Martin Hatzinger, Solothurn

13:30-13:50



  Stress-related changes in reward and punishment
processing in mice
Christopher R. Pryce, Zürich

13:50-14:10


  Cross-species models of defensive emotions
Dominik R. Bach, London; UK

14:10-14:30


  Genetics and Epigenetics of Stress and Emotion
Marcus Ising, München; Germany

14:30-14:45
Singapore

  SGBP | SSPB Young Investigator Award


14:45-15:45
Foyer



  Posterviewing
SGVN|SSNC: Jean-Marie Annoni, Fribourg
SNG | SSN: Michael Linnebank, Zürich
SGBP| SSBP: Jean-Michel Aubry, Genève

15:45-17:15
Montreal

  Datablitz Session
Chair: Edith Holsboer-Trachsler, Basel

15:45-15:51   Insights into Mitochondrial Dynamics in Alzheimer’s Disease
K. Schmitt, S.A. Brown, S. Frank, A. Eckert; Basel, Zürich

15:51-15:57   Amyloid- ß peptide, estradiol and mitochondrial dysfunction in Alzheimer’s disease
A. Grimm, Y.A. Lim, M. Giese, A.G. Mensah-Nyagan, J. Gôtz, A. Eckert; Basel, Solothurn

15:57-16:03   An impaired synaptic homeostasis underlies the appearance of levodopa-induced dyskinesia: an electrophysiological study in a rat model
M. Pace, S. Sarasso, F. Baracchi, U. Faraguna, A. Salvadè, C. Bassetti, J.C. Moeller, S. Galati; Lugano, Bern, Pisa (IT), Milano (IT)

16:03-16:09   Lesioning of the posterior insula and deep gray matter releases pathological yawning in stroke patients H. Krestel, C. Weisstanner, J. Mathys, C. Hess, C. Bassetti, R. Wiest; Bern

16:09-16:15   Pooled Analysis of Responder Rates and Seizure Freedom from Phase III Clinical Trials of Adjunctive Perampanel, a Selective, Non-Com- petitive AMPA Receptor Antagonist
G. Krauss, E. Perucca, M. Brodie, J. French, D. Squillacote, H. Yang,
D. Kumar, A. Laurenza; Baltimore (US), Pavia (IT), Glasgow (UK), New York (US)

16:15-16:21   Psychogenic tetraparesis and bilateral upper limb dystonia, regressive under short propofol-induced sedation and during hepatic encephalopathy
F. Medlin, S. Aybek, A. Berney, E. Guedj, A. Bischof Delaloye, J.O. Prior, K. Diserens; Lausanne, Marseille (FR)

16:21-16:27   Reperfusion drives ubiquitin aggregate formation in experimental stroke, and requires both - oxygen and glucose
T. Kahles, K. Hochrainer, K. Jackman, J. Anrather, C. Iadecola; Aarau, New York (US)

16:27-16:33   The CoHead – Study: Copeptin as an independent and additive biomarker in acute headache
K. Haaf, C.A. Blum, P. Schütz, M. Katan, S. Biethahn, B. Winzeler, N. Nigro, K. Timper, J. Tepperberg, A. Huber, U.W. Buettner, B. Mueller, M. Christ-Crain; Aarau, Basel, Zürich

16:33-16:39   A double double-blind, randomized trial to treat patients suffering from OCD with or without adjuvant memantine
M. Haghighi, L. Jahangard, H. Bajoghli, E. Holsboer-Trachsler, S. Brand; Hamadan (Iran), Tehran (Iran), Basel

16:39-16:45   Cognitive training in patients with juvenile multiple sclerosis
I.K. Penner, M. Hubacher, L. Kappos, M. Stoecklin, K. Opwis, P. Weber; Basel

16:45-16:51   Mortality and recovery from refractory status epilepticus: a 7-year observation
R. Sutter, S. Marsch, P. Fuhr, S. Rüegg; Basel, Baltimore (US)

16:51-16:57   Safety and efficacy of lacosamide for adjunctive treatment of refractory status epilepticus: a large comparative cohort study
R. Sutter, S. Marsch, S. Rüegg; Basel, Baltimore (US)

16:57-17:03   Early BDNF serum level changes in depressed patients treated with duloxetine are associated with early response to treatment (≥20% HAMD score decrease) and positive therapeutic outcome
A. Delini-Stula, E. Holsboer-Trachsler, T. Mikoteit, J. Beck, U. Hemmeter, A. Eckert; Basel, Wil

17:03-17:09   Cognitive performance is impaired during occupational burnout but recovers after improvement of burnout severity
J. Beck, M. Gerber, S. Brand, U. Puehse, E. Holsboer-Trachsler; Basel

17:09-17:15   Childhood maltreatment and methylation of the glucocorticoid receptor gene (NR3C1) in bipolar disorder
N. Perroud, A. Dayer, C. Piguet, A. Nallet, S. Favre, A. Malafosse, J.M. Aubry; Geneva

17:15-17:45

  Kaffeepause in der Industrieausstellung

17:45-19:15
Montreal

  Generalversammlung SNG


17:45-18:45
Singapore

  Generalversammlung SGBP


ab 19:30

  Gesellschaftsabend mit Preisverleihung